Lenvatinib plus EGFR inhibition for liver cancer
- PMID: 34404918
- DOI: 10.1038/s41575-021-00513-6
Lenvatinib plus EGFR inhibition for liver cancer
Comment on
-
EGFR activation limits the response of liver cancer to lenvatinib.Nature. 2021 Jul;595(7869):730-734. doi: 10.1038/s41586-021-03741-7. Epub 2021 Jul 21. Nature. 2021. PMID: 34290403
References
Original article
-
- Jin, H. et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature 595, 730–734 (2021) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
